Company Solutions

Teva has a pipeline of 3500 products including, Generic medicines, Over the counter medicines & active pharmaceutical Ingredients (API), medical devices and more

Generics

At Teva we believe that every one of us should have access to quality medicine that helps manage disease, fight infection, or simply improves overall health. That is why a substantial part of our business today and a significant portion of our research and development budget is focused on generic medicines.

World leader in Generic Medicines with over 1800 molecules and over 500 therapies in the following TA's: Respiratory, oncology, antibiotics/ anti-infectives, cardiovascular, pain, mental health

Biopharmaceuticals

Biopharmaceuticals are complex medicines made from biological material. They advance more treatment options for patients, some of whom suffer from untreated or undertreated conditions. They have the potential to deliver precise and personalized treatment.

Teva has 5 biopharmaceuticals in the market today. In addition, we have approximately 20 original biologic and biosimilar programs in various phases of development, from discovery through to clinical and regulatory stages

Specialty Medicines

We invest decades and millions of dollars into research and science. Our specialty medicines and our biopharmaceuticals provide innovative treatments for conditions that are sometimes untreated or undertreated
Teva's Specialty Therapeutic areas of focus are:

• Migraine and headache
• Movement disorders, neurodegeneration, Psychiatry
• Pain
• Respiratory

Today Teva has Leading specialty products to treat Central Nervous System Disorders including Migraine, HD, MS as well as leading specialty products for respiratory indications

Looking For

We're interested in Innovations and developments in our main focus areas including Gx, OTC, and specialty in core therapeutic areas

• Migraine and headache
• Movement disorders and neurodegeneration
• Pain
• Respiratory

With a high focus on:

• Biologics as a core R&D platform: We strive to develop leading capabilities in biotech - including highly innovative antibodies, biosimilars, biologics discovery and our own biologic manufacturing capacity for Oncology and other indications
• Small molecules primarily for CNS diseases.
• Respiratory: Focused on Patient-centric solutions – biologics ,technology, services, unique devices
• Innovations in the field of Clinical Trial innovation and clinical operations
• Innovations in Gx development and manufacturing